Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized Controlled Trial of VES-0-D Gel, an Investigational Alginol, Versus Standard Care in the Management of Wagner Grade 1 or 2 Diabetic Foot Ulcers Over 8 Weeks

NCT07783087 is registered in ClinicalTrials.gov with Flen Health as lead sponsor.

NCT NCT07783087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07783087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized Controlled Trial of VES-0-D Gel, an Investigational Alginol, Versus Standard Care in the Management of Wagner Grade 1 or 2 Diabetic Foot Ulcers Over 8 Weeks
Lead sponsor
Flen Health
Phase
Not applicable
Overall status
Recruiting
Start date
August 10, 2026
Completion date
October 31, 2027
Enrollment
64 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer (dfu)